CORRELATION BETWEEN OBESITY AND TESTOSTERONE LEVEL, ANXIETY SYMPTOMS, DEPRESSION AND ACCELERATED AGING IN MEN
https://doi.org/10.15372/SSMJ20180113
Abstract
The aim of the investigation was to study the relationship of blood testosterone levels with the severity of anxiety signs, depression and urological pathology symptoms in men of mature age with normal weight, overweight and obesity. Material and methods: 188 men of 36.7 average age participated in the study. Anthropometric examination was carried out, the HADS questionnaire (Hospital Anxiety and Depression Scale, 1983) was used to assess the level of anxiety and depression; the severity of urinary disorders symptoms was evaluated with the scale of IPSS (International Prostate Symptom Score). To study the sexual dysfunction the international index of erectile dysfunction (ICEF-5) was applied. AMS Men's Age Symptoms (Aging Males Symptoms) questionnaire was used to identify clinical signs of androgen deficiency. The content of testosterone and cortisol in blood serum was determined by EIA. Results and discussion: The growth of androgen deficiency along with the increase in the urinary disorders symptoms, extended anxiety, depression and enhanced signs of erectile dysfunction have been revealed in men with overweight and obesity relating to the men with normal body weight. The androgen deficiency growth influences the aging processes acceleration. In turn, the presence of urological pathology in men can plays an important role in the obesity pathogenesis through the increase in anxiety and depression.
Keywords
About the Authors
O. V. Vasileva
Research Institute of Experimental and Clinical Medicine
Russian Federation
Russian Federation
V. G. Selyatitskaya
Research Institute of Experimental and Clinical Medicine
Russian Federation
Russian Federation
References
1. Дедов И.И., Мельниченко Г.А., Роживанов Р.В., Курбатов Д.Г. Рекомендации по диагностике и лечению гипогонадизма (дефицита тестостерона) у мужчин // Пробл. эндокринологии. 2015. 61. (5). 60-71.
2. Епанчинцева Е.А., Селятицкая В.Г., Шеина Ю.И. Параметры эякулята у пациентов с абдоминальным ожирением // Андрол. и генит. хирургия. 2015. 16. (1). 88-93.
3. Иванченко Д.Н., Дорофеева Н.П., Шлык С.В. Депрессивные расстройства у больных сердечно-сосудистыми заболеваниями: влияние на прогноз // Мед. вестн. Юга России. 2016.(1). 28-32.
4. Искандеров Б.Г. Аффективные расстройства и нарушения ритма сердца. Пенза, 2011. 168 с.
5. Пальцев М.А., Кветной И.М., Полякова В.О., Кветная Т.В., Трофимов А.В. Нейроиммуноэндокринные механизмы старения // Успехи геронтологии. 2009. 22. (1). 24-36.
6. Пат. № 2387374 РФ. Способ определения биологического возраста человека и скорости старения / А.Г. Горелкин, Б.Б. Пинхасов; Опубл. 27.04.2010.
7. Соболева Н.П., Руднев С.Г., Николаев Д.В., Ерюкова Т.А., Колесников В.А., Мельниченко О.А., Пономарева Е.Г., Старунова О.А., Стерликов С.А. Биоимпедансный скрининг населения России в центрах здоровья: распространенность избыточной массы тела и ожирения // Рос. мед. журн. 2014. (4). 4-13.
8. Узбеков М.Г., Максимова Н.М. Моноамино-гормональные связи в патогенезе тревожной депрессии // Журн. неврологии и психиатрии. 2015. 1. (2). 52-55.
9. Celec P., Ostatnikova D., Hodosy J. On the effects of testosterone on brain behavioral functions // Front. Neurosci. 2015. 9. 12.
10. Fugh-Berman A., Scialli A.R. Testosterone and sexual function // Curr. Opin. Urol. 2017. 27. (6). 516-518.
11. Khera M. Patients with testosterone deficiency syndrome and depression // Arch. Esp. Urol. 2013. 66. (7). 729-736.
12. Kim E.Y., Kim S.H., Ha K., Lee H.J., Yoon D.H., Ahn Y.M. Depression trajectories and the association with metabolic adversities among the middle-aged adults // J. Affect. Disord. 2015. 188. 14-21.
13. Novikova E., Selyatitskaya V., Mitrofanov I., Pinkhasov B., Karapetyan A. Association of erectile dysfunction and hypogonadism with metabolic syndrome in men with lower urinary tract symptoms of younger and older age groups // Adv. Sex. Med. 2014. 4. 55-64.
14. Penninx B.W.J.H., Milaneschi Y., Lamers F., Vogelzangs N. Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile // BMC Med. 2013. 11. 129.
15. Shabsigh R., Arver S., Channer K.S., Eardley I., Fabbri A., Gooren L., Heufelder A., Jones H., Meryn S., Zitzmann M. The triad of erectile dysfunction, hypogonadism and the metabolic syndrome // Int. J. Clin. Pract. 2008. 62. (5). 791-798.
16. Suija K., Kerkela M., Rajala U., Jokelainen J., Laakso M., Harkonen P., Keinanen-Kiukaanniemi S., Timonen M. The association between erectile dysfunction, depressive symptoms and testosterone levels among middle-aged men // Scand. J. Public Health. 2014. 42. (7). 677-682.
17. Westley C.J., Amdur R.L., Irwig M.S. High rates of depression and depressive symptoms among men referred for borderline testosterone levels // J. Sex. Med. 2015. 12. (8). 1753-1760.
18. Yassin A.A., Nettleship J.E., Salman M., Almehmadi Y. Waist circumference is superior to weight and BMI in predicting sexual symptoms, voiding symptoms and psychosomatic symptoms in men with hypogonadism and erectile dysfunction // Andrologia. 2017.49.(4).e12634.
Review
Views:
655
Email this article 